; (2) in subparagraph (K), by striking the period at the end and inserting ; or ; and (3) by adding at the end the following: (L) if the drug is a drug described in paragraph (2)(A)(ix) and the applicant has not proposed technologies, controls, or measures related to the packaging or disposal of such drug that the Secretary determines are comparably effective to those required for the applicable listed drug under section 505–2. . (e) Rules of construction (1) Any labeling describing technologies, controls, or measures related to packaging, storage, or disposal intended to mitigate the risk of abuse or misuse of a drug product that is subject to an abbreviated new drug application, including labeling describing differences from the reference listed drug resulting from the application of section 505–2 of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a), shall not be construed— (A) as changes to labeling not permissible under clause (v) of section 505(j)(2)(A) of such Act ( 21 U.S.C. 355(j)(2)(A) ), or a change in the conditions of use prescribed, recommended, or suggested in the labeling proposed for the new drug under clause (i) of such section